drugset / Trial / NCT04766463

A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.

NCT04766463

Phase 3 Completed 528 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery

Timeline

Start
2021-03-03
Primary completion
2021-10-19
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject SHR8554 Unknown Intravenous

Indications

No indication recorded.